Papassotiropoulos A - Search Results

1

Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.

Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, Rao ML, Maier W, Björkhem I, von Bergmann K, Heun R. Papassotiropoulos A, et al. Neuroreport. 2000 Jun 26;11(9):1959-62. doi: 10.1097/00001756-200006260-00030. Neuroreport. 2000. PMID: 10884051

2

Cerebrospinal fluid levels of beta-amyloid(42) in patients with Alzheimer's disease are related to the exon 2 polymorphism of the cathepsin D gene.

Papassotiropoulos A, Lewis HD, Bagli M, Jessen F, Ptok U, Schulte A, Shearman MS, Heun R. Papassotiropoulos A, et al. Neuroreport. 2002 Jul 19;13(10):1291-4. doi: 10.1097/00001756-200207190-00015. Neuroreport. 2002. PMID: 12151789

3

Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease.

Papassotiropoulos A, Bagli M, Feder O, Jessen F, Maier W, Rao ML, Ludwig M, Schwab SG, Heun R. Papassotiropoulos A, et al. Neurosci Lett. 1999 Mar 12;262(3):171-4. doi: 10.1016/s0304-3940(99)00071-3. Neurosci Lett. 1999. PMID: 10218883

4

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

Papassotiropoulos A, Bagli M, Jessen F, Bayer TA, Maier W, Rao ML, Heun R. Papassotiropoulos A, et al. Ann Neurol. 1999 May;45(5):666-8. doi: 10.1002/1531-8249(199905)45:5<666::aid-ana18>3.0.co;2-3. Ann Neurol. 1999. PMID: 10319892

5

Early-onset and late-onset depression are independent of the genetic polymorphism of apolipoprotein E.

Papassotiropoulos A, Bagli M, Jessen F, Rao ML, Schwab SG, Heun R. Papassotiropoulos A, et al. Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):258-61. doi: 10.1159/000017129. Dement Geriatr Cogn Disord. 1999. PMID: 10364642 Free article. Clinical Trial.

6

No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a German population.

Bagli M, Papassotiropoulos A, Schwab SG, Jessen F, Rao ML, Maier W, Heun R. Bagli M, et al. Among authors: papassotiropoulos a. J Neurol Sci. 1999 Aug 1;167(1):34-6. doi: 10.1016/s0022-510x(99)00131-8. J Neurol Sci. 1999. PMID: 10500259

7

Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.

Schwab SG, Bagli M, Papassotiropoulos A, Jessen F, Maier W, Rao ML, Heun R. Schwab SG, et al. Among authors: papassotiropoulos a. Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):469-72. doi: 10.1159/000017191. Dement Geriatr Cogn Disord. 1999. PMID: 10559561 Clinical Trial.

8

Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.

Lütjohann D, Papassotiropoulos A, Björkhem I, Locatelli S, Bagli M, Oehring RD, Schlegel U, Jessen F, Rao ML, von Bergmann K, Heun R. Lütjohann D, et al. Among authors: papassotiropoulos a. J Lipid Res. 2000 Feb;41(2):195-8. J Lipid Res. 2000. PMID: 10681402 Free article.

9

A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease.

Papassotiropoulos A, Bagli M, Kurz A, Kornhuber J, Förstl H, Maier W, Pauls J, Lautenschlager N, Heun R. Papassotiropoulos A, et al. Ann Neurol. 2000 Mar;47(3):399-403. Ann Neurol. 2000. PMID: 10716266

10

Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease.

Papassotiropoulos A, Bagli M, Jessen F, Frahnert C, Rao ML, Maier W, Heun R. Papassotiropoulos A, et al. Mol Psychiatry. 2000 Mar;5(2):213-5. doi: 10.1038/sj.mp.4000656. Mol Psychiatry. 2000. PMID: 10822352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters